Humacyte, Inc. (HUMA)
(Delayed Data from NSDQ)
$5.25 USD
-0.14 (-2.60%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $5.24 -0.01 (-0.19%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Humacyte, Inc. (HUMA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$10.17 | $15.00 | $6.00 | 88.68% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Humacyte, Inc. comes to $10.17. The forecasts range from a low of $6.00 to a high of $15.00. The average price target represents an increase of 88.68% from the last closing price of $5.39.
Analyst Price Targets (6 )
Broker Rating
Humacyte, Inc. currently has an average brokerage recommendation (ABR) of 1.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.33 a month ago based on six recommendations.
Of the seven recommendations deriving the current ABR, six are Strong Buy, representing 85.71% of all recommendations. A month ago, Strong Buy represented 83.33%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/HUMA.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.29 | 1.33 | 1.33 | 1.33 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/9/2024 | EF Hutton Financial | Jason Kolbert | Not Available | Strong Buy |
8/12/2024 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
8/12/2024 | Piper Sandler | Allison M Bratzel | Hold | Hold |
7/15/2024 | BTIG | Ryan Zimmerman | Strong Buy | Strong Buy |
7/2/2024 | Cantor Fitzgerald & Co | Kristen Kluska | Strong Buy | Strong Buy |
7/2/2024 | The Benchmark Company | Bruce D Jackson | Strong Buy | Strong Buy |
4/1/2024 | H.C. Wainwright & Co. | Vernon Bernardino | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.29 |
ABR (Last week) | 1.33 |
# of Recs in ABR | 7 |
Average Target Price | $10.17 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 83 of 253 |
Current Quarter EPS Est: | -0.25 |
HUMA FAQs
Humacyte, Inc. (HUMA) currently has an average brokerage recommendation (ABR) of 1.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Humacyte, Inc. (HUMA) is $12.29. The current on short-term price targets is based on 4 reports.
The forecasts for Humacyte, Inc. (HUMA) range from a low of $6 to a high of $25. The average price target represents a increase of $134.10 from the last closing price of $5.25.
The current UPSIDE for Humacyte, Inc. (HUMA) is 134.10%
Based on short-term price targets offered by six analysts, the average price target for Humacyte, Inc. comes to $10.17. The forecasts range from a low of $6.00 to a high of $15.00. The average price target represents an increase of 88.68% from the last closing price of $5.39.